Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1501-1510

  Håvik, Bjarte ^a   Bramham, Clive R ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Hsc70; Hsp70; Hsp90

Indexed keywords

HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; HSC70 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 34548030229     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1501     Document Type: Article

References (47)

1. Hu W and Kavanagh JJ: Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4: 721-729, 2003. (Pubitemid 37527207)
2. Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ and McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85: 570-574, 1993. (Pubitemid 23110932)
3. Vargas-Roig LM, Fanelli MA, Lopez LA, Gago FE, Tello O, Aznar JC and Ciocca DR: Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 21: 441-451, 1997. (Pubitemid 27413987)
4. Malusecka E, Zborek A, Krzyzowska-Gruca S and Krawczyk Z: Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study. Anticancer Res 21: 1015-1021, 2001.
5. Lazaris AC, Theodoropoulos GE, Davaris PS, Panoussopoulos D, Nakopoulou L, Kittas C and Golematis BC: Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer. Dis Colon Rectum 38: 739-745, 1995.
6. Nanbu K, Konishi I, Mandai M, Kuroda H, Hamid AA, Komatsu T and Mori T: Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect Prev 22: 549-555, 1998. (Pubitemid 28537438)
7. Syrigos KN, Harrington KJ, Karayiannakis AJ, Sekara E, Chatziyianni E, Syrigou EI and Waxman J: Clinical significance of heat shock protein-70 expression in bladder cancer. Urology 61: 677-680, 2003. (Pubitemid 36294216)
8. Kaur J, Srivastava A and Ralhan R: Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity. Oral Oncol 34: 496-501, 1998. (Pubitemid 28546864)
9. Samali A and Cotter TG: Heat shock proteins increase resistance to apoptosis. Exp Cell Res 223: 163-170, 1996. (Pubitemid 26063934)
10. Grossin L, Etienne S, Gaborit N, Pinzano A, Cournil-Henrionnet C, Gerard C, Payan E, Netter P, Terlain B and Gillet P: Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo. Clin Hemorheol 41: 521-534, 2004. (Pubitemid 39277108)
11. Rashmi R, Kumar S and Karunagaran D: Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis 25: 179-187, 2004. (Pubitemid 38239801)
12. Gyrd-Hansen M, Nylandsted J and Jaattela M: Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity. Cell Cycle 3: 1484-1485, 2004. (Pubitemid 40521395)
13. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F and Jaattela M: Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97: 7871-7876, 2000. (Pubitemid 30460740)
14. Nylandsted J, Wick W, Hirt UA, Brand K, Rohde M, Leist M, Weller M and Jaattela M: Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 62: 7139-7142, 2002. (Pubitemid 36025225)
15. Mosser DD, Caron AW, Bourget L, Denis-Larose C and Massie B: Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17: 5317-5327, 1997. (Pubitemid 27357630)
16. Jaattela M, Wissing D, Kokholm K, Kallunki T and Egeblad M: Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17: 6124-6134, 1998. (Pubitemid 28497786)
17. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A and Kuwana T, Tailor P, Morimoto RI, Cohen GM and Green DR: Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2: 469-475, 2000.
18. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI and Massie B: The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20: 7146-7159, 2000.
19. Gabai VL, Mabuchi K, Mosser DD and Sherman MY: Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol Cell Biol 22: 3415-3424, 2002. (Pubitemid 34453981)
20. Gotoh T, Terada K, Oyadomari S and Mori M: hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 11: 390-402, 2004. (Pubitemid 38489417)
21. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J and Jaattela M: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 19: 570-582, 2005. (Pubitemid 40314989)
22. Prodromou C and Pearl LH: Structure and functional relationships of Hsp90. Curr Cancer Drug Targets 3: 301-323, 2003. (Pubitemid 37128317)
23. Chiosis G, Vilenchik M, Kim J and Solit D: Hsp90: the vulnerable chaperone. Drug Discov Today 9: 881-888, 2004. (Pubitemid 39314553)
24. Zhang H and Burrows F: Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 82: 488-499, 2004. (Pubitemid 39149859)
25. Xu W, Mimnaugh EG, Kim JS, Trepel JB and Neckers LM: Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2. Cell Stress Chaperones 7: 91-96, 2002. (Pubitemid 36138907)
26. Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y and Neckers L: Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem 276: 3702-3708, 2001.
27. Zhou P, Fernandes N, Dodge IL, Reddi AL, Rao N, Safran H, DiPetrillo TA, Wazer DE, Band V and Band H: ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 278: 13829-13837, 2003. (Pubitemid 36799921)
28. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C and Neckers L: Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci USA 99: 12847-12852, 2002.
29. Choudhury A, Charo J, Parapuram SK, Hunt RC, Hunt DM, Seliger B and Kiessling R: Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int J Cancer 108: 71-77, 2004. (Pubitemid 37444446)
30. Lai D, Weng S, Wang C, Qi L, Yu C, Fu L and Chen W: Small antisense RNA to cyclin D1 generated by pre-tRNA splicing inhibits growth of human hepatoma cells. FEBS Lett 576: 481-486, 2004. (Pubitemid 39388649)
31. Faltus T, Yuan J, Zimmer B, Kramer A, Loibl S, Kaufmann M and Strebhardt K: Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia 6: 786-795, 2004. (Pubitemid 40041497)
32. Demand J, Luders J and Hohfeld J: The carboxy-terminal domain of Hsc70 provides binding sites for a distinct set of chaperone cofactors. Mol Cell Biol 18: 2023-2028, 1998. (Pubitemid 28152651)
33. Kosano H, Stensgard B, Charlesworth MC, McMahon N and Toft D: The assembly of progesterone receptor-hsp90 complexes using purified proteins. J Biol Chem 273: 32973-32979, 1998. (Pubitemid 28557691)
34. Dittmar KD, Banach M, Galigniana MD and Pratt WB: The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex. J Biol Chem 273: 7358-7366, 1998. (Pubitemid 28152756)
35. Hartmann F, Horak EM, Cho C, Lupu R, Bolen JB, Stetler-Stevenson MA, Pfreundschuh M, Waldmann TA and Horak ID: Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines. Int J Cancer 70: 221-229, 1997. (Pubitemid 27107421)
36. Wegele H, Muller L and Buchner J: Hsp70 and Hsp90 - a relay team for protein folding. Rev Physiol Biochem Pharmacol 151: 1-44, 2004.
37. Fourie AM, Peterson PA and Yang Y: Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2. Cell Stress Chaperones 6: 282-295, 2001. (Pubitemid 32912013)
38. Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N and Bhalla K: Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res 65: 10536-10544, 2005. (Pubitemid 41743748)
39. Nishimura RN, Santos D, Esmaili L, Fu ST and Dwyer BE: Expression of antisense hsp70 is a major determining factor in heat-induced cell death of P-19 carcinoma cells. Cell Stress Chaperones 5: 173-180, 2000.
40. Nunes SL and Calderwood SK: Heat shock factor-1 and the heat shock cognate 70 protein associate in high molecular weight complexes in the cytoplasm of NIH-3T3 cells. Biochem Biophys Res Commun 213: 1-6, 1995.
41. Guo Y, Guettouche T, Fenna M, Boellmann F, Pratt WB, Toft DO, Smith DF and Voellmy R: Evidence for a mechanism of repression of heat shock factor 1 transcriptional activity by a multichaperone complex. J Biol Chem 276: 45791-45799, 2001.
42. Kim HR, Kang HS and Kim HD: Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells. IUBMB Life 48: 429-433, 1999.
43. Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC, Sessa WC and Altieri DC: Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 100: 13791-13796, 2003. (Pubitemid 37499145)
44. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, Weichselbaum R, Nalin C, Alnemri ES, Kufe D and Kharbanda S: Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19: 4310-4322, 2000. (Pubitemid 30623742)
45. An WG, Schnur RC, Neckers L and Blagosklonny MV: Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity. Cancer Chemother Pharmacol 40: 60-64, 1997. (Pubitemid 27160962)
46. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY and Patterson C: Identification of CHIP, a novel tetratrico-peptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19: 4535-4545, 1999. (Pubitemid 29242026)
47. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J and Patterson C: The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3: 93-96, 2001. (Pubitemid 32114838)